Vivos Inc. (OTCMKTS:RDGL – Get Free Report)’s share price was up 3.4% on Monday . The stock traded as high as $0.14 and last traded at $0.13. Approximately 1,133,800 shares traded hands during mid-day trading, a decline of 15% from the average daily volume of 1,328,104 shares. The stock had previously closed at $0.13.
Vivos Trading Up 12.7 %
The business’s 50-day simple moving average is $0.15 and its 200-day simple moving average is $0.13. The company has a market cap of $63.38 million, a PE ratio of -15.16 and a beta of 1.01.
Vivos Company Profile
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Further Reading
- Five stocks we like better than Vivos
- How to Buy Cheap Stocks Step by Step
- Marvell Technology AI Boom is Just Getting Started with ASIC
- What are earnings reports?
- Trends Investors Should Watch This Quarter for Market Insights
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Homebuilders Poised for a Breakout: Top Stocks to Watch
Receive News & Ratings for Vivos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos and related companies with MarketBeat.com's FREE daily email newsletter.
